BridgeBio Pharma (BBIO) Inventory Average (2025 - 2026)

BridgeBio Pharma (BBIO) reported Inventory Average of $29.9 million for Q1 2026, up 16.48% sequentially from $25.6 million in Q4 2025.

BridgeBio Pharma (BBIO) Inventory Average (2025 - 2026) Analysis & Trends

BridgeBio Pharma (BBIO) has 2 years of Inventory Average data on file, last reported at $29.9 million in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	644.91 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	1.73 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	3.15 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	BridgeBio Pharma	16.15 Bn	15.22 Bn	184.58 Mn	29.87 Mn

Download Data